![](/images/2013/post-sep.jpg)
Oscillating Positive Expiratory Pressure Device Market Set for Remarkable Growth to Reach USD 263.40 Million by 2034
The adoption of OPEP devices for pediatric and geriatric populations is gaining traction in Japan creating a substantial market demand.
NEWARK, DE, UNITED STATES, February 12, 2025 /EINPresswire.com/ -- The global oscillating positive expiratory pressure (OPEP) device market is experiencing significant growth, with recent analyses projecting its valuation to reach USD 151.30 million by the end of 2024. This momentum is anticipated to continue, with forecasts indicating a substantial increase to USD 263.40 million by 2034, reflecting a steady Compound Annual Growth Rate (CAGR) of 5.70% during the forecast period.
OPEP devices are becoming indispensable tools in respiratory therapy, designed to assist patients in clearing mucus from their lungs. The increasing adoption of these devices is primarily driven by the rising prevalence of chronic respiratory conditions, including chronic obstructive pulmonary disease (COPD) and asthma. Furthermore, advancements in respiratory therapy technologies are significantly bolstering the demand for these devices, which have proven to enhance patient outcomes and quality of life.
๐๐ข๐ฌ๐๐จ๐ฏ๐๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐ก๐ข๐๐ญ๐ฌ: ๐๐๐๐ฎ๐ซ๐ ๐๐จ๐ฎ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐ฐ! https://www.futuremarketinsights.com/report-sample#5245502d47422d33333937
As healthcare systems worldwide emphasize effective respiratory treatments, the demand for innovative solutions like OPEP devices is set to surge. "The OPEP device market is experiencing steady growth, fueled by increased awareness of respiratory health, rising incidence of respiratory diseases, and innovations in medical system infrastructure. The growing demand for respiratory therapy solutions underscores the market's investment potential," stated an analyst at Future Market Insights (FMI).
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
Currently, North America and Europe dominate the OPEP device market, benefiting from well-established healthcare infrastructures and heightened awareness of respiratory therapies. However, East Asia is projected to emerge as a lucrative market from 2024 to 2034, driven by increased local production and the availability of more affordable products. The growing prevalence of COPD, largely due to smoking in China, along with rising respiratory illnesses among the elderly in Japan, are key contributors to this regional expansion.
Despite this positive growth outlook, the market faces challenges, particularly the low awareness of OPEP devices among healthcare practitioners and patients in certain regions. Addressing this knowledge gap will be crucial for unlocking the marketโs full potential.
With a robust trajectory ahead, the OPEP device market is well-positioned for significant growth, driven by the escalating need for effective respiratory therapies and technological advancements that enhance patient care.
๐๐๐ฒ ๐๐๐ค๐๐๐ฐ๐๐ฒ๐ฌ:
โข The Oscillating Positive Expiratory Pressure (OPEP) Device Market is expected to hold a 33.70% share in the indication category by 2024.
โข Mouthpiece PEP devices are projected to dominate with a 96.80% market share in 2024.
โข Italyโs OPEP device market is set to grow at a CAGR of 5.20% from 2024 to 2034.
โข Germany and China are leading with CAGRs of 5.60% and 6.00%, respectively, through 2034.
โข The United States and Japan are also expected to see significant growth, with CAGRs of 5.40% and 5.60%, respectively.
๐๐๐ญ ๐ญ๐ก๐ ๐๐๐ญ๐๐ฌ๐ญ ๐จ๐ง ๐๐ฌ๐๐ข๐ฅ๐ฅ๐๐ญ๐ข๐ง๐ ๐๐จ๐ฌ๐ข๐ญ๐ข๐ฏ๐ ๐๐ฑ๐ฉ๐ข๐ซ๐๐ญ๐จ๐ซ๐ฒ ๐๐ซ๐๐ฌ๐ฌ๐ฎ๐ซ๐ (๐๐๐๐) ๐๐๐ฏ๐ข๐๐: ๐๐ฎ๐ซ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐๐๐ฒ ๐๐ซ๐๐ง๐๐ฌ ๐๐ง๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ! https://www.futuremarketinsights.com/reports/oscillating-positive-expiratory-pressure-opep-devices-market
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐:
The OPEP device market is highly competitive, with several key players engaged in strategic partnerships and new product launches to capture market share.
๐๐จ๐ญ๐๐๐ฅ๐ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ ๐ข๐ง๐๐ฅ๐ฎ๐๐:
โข Smithโs Medical launched the Acapella Choice Blue vibratory PEP therapy system in April 2021.
โข AirPhysio received FDA approval in January 2021 for its Positive Expiratory Pressure (PEP) Device.
๐๐ฌ๐ฌ๐๐ง๐ญ๐ข๐๐ฅ ๐๐ฌ๐๐ข๐ฅ๐ฅ๐๐ญ๐ข๐ง๐ ๐๐จ๐ฌ๐ข๐ญ๐ข๐ฏ๐ ๐๐ฑ๐ฉ๐ข๐ซ๐๐ญ๐จ๐ซ๐ฒ ๐๐ซ๐๐ฌ๐ฌ๐ฎ๐ซ๐ (๐๐๐๐) ๐๐๐ฏ๐ข๐๐ ๐๐๐ง๐ฎ๐๐๐๐ญ๐ฎ๐ซ๐๐ซ๐ฌ:
โข Smithโs Medical, Inc.
โข Allergan plc
โข Monaghan Medical Corporation & Trudell Medical International
โข PARI GmbH
โข WyMedical Pty Ltd
โข R. Cegla GmbH & Co. KG
โข D-R BURTON HEALTHCARE
โข AirPhysio
โข Medica Holdings, LLC.
๐๐๐ค๐ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ ๐๐๐๐ข๐ฌ๐ข๐จ๐ง๐ฌ ๐ข๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐ฐ๐ข๐ญ๐ก ๐๐ฑ๐ฉ๐๐ซ๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ! https://www.futuremarketinsights.com/industry-analysis/therapeutic-device
๐๐๐ฒ ๐๐๐ ๐ฆ๐๐ง๐ญ๐ฌ:
โข ๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐๐ญ ๐๐ฒ๐ฉ๐: Face Mask PEP Devices, Mouthpiece PEP Devices, Bottle PEP Devices
โข ๐๐ฒ ๐๐ง๐๐ข๐๐๐ญ๐ข๐จ๐ง: COPD, Asthma, Atelectasis, Bronchitis, Bronchiectasis, Cystic Fibrosis, Others
โข ๐๐ฒ ๐๐ข๐ฌ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐จ๐ง ๐๐ก๐๐ง๐ง๐๐ฅ: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
โข ๐๐ฒ ๐๐๐ ๐ข๐จ๐ง: North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA)
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐ ๐๐โ๐ฌ ๐๐๐ฅ๐๐ญ๐๐ ๐๐ง๐ ๐จ๐ข๐ง๐ ๐๐จ๐ฏ๐๐ซ๐๐ ๐ ๐จ๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐๐จ๐ฆ๐๐ข๐ง:
๐๐ฅ๐จ๐๐๐ฅ ๐๐ฅ๐จ๐จ๐ ๐๐ซ๐๐ฌ๐ฌ๐ฎ๐ซ๐ ๐๐จ๐ง๐ข๐ญ๐จ๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ โ ๐๐ข๐ณ๐, ๐๐ซ๐๐ง๐๐ฌ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐: https://www.futuremarketinsights.com/reports/blood-pressure-monitor-market
๐๐ฎ๐๐ฎ๐ฌ ๐๐ฅ๐๐๐ซ๐๐ง๐๐ ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ โ ๐๐ซ๐จ๐ฐ๐ญ๐ก & ๐๐๐ฆ๐๐ง๐ ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐: https://www.futuremarketinsights.com/reports/mucus-clearance-devices-market
๐๐๐ง๐ ๐๐๐ข๐ญ๐ข๐ง๐ ๐๐จ๐จ๐ฅ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ โ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ซ๐๐ง๐๐ฌ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐: https://www.futuremarketinsights.com/reports/gene-editing-tools-market
๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐๐ง๐๐จ๐ฅ๐จ๐ ๐ฒ ๐๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก โ ๐๐ซ๐๐ง๐๐ฌ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐: https://www.futuremarketinsights.com/reports/clinical-oncology-next-generation-sequencing-market
๐๐๐ ๐๐ก๐จ๐ฅ๐๐ฌ๐ญ๐๐ซ๐จ๐ฅ ๐๐ข๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก โ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ซ๐๐ง๐๐ฌ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐: https://www.futuremarketinsights.com/reports/hdl-cholesterol-kits-market
๐๐๐จ๐ฎ๐ญ ๐ ๐ฎ๐ญ๐ฎ๐ซ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ (๐ ๐๐)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
Ankush Nikam
Future Market Insights, Inc.
+91 90966 84197
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube
![](https://nanotech.einnews.com/tracking/article.gif?aid=785269491§ion=einpresswire&a=v3jjvxZ20kmFEmln&i=Oi6g9zfDmxEoURhw)
Distribution channels: Healthcare & Pharmaceuticals Industry
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release